Skip to Main Content

Paper Details

Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.
Ophthalmology
46
2021
Author NameAffiliation
Philip J RosenfeldUniversity of Miami Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Nadia K WaheedTufts Medical Center
Rishi P SinghCole Eye Institute, Cleveland Clinic
Giovanni StaurenghiUniversity of Milan-Bicocca: Universita degli Studi di Milano-Bicocca
Ramiro RibeiroApellis Pharmaceuticals
  • 1 - 5

Datasets